EURETINA 2022: Dr. Jager Presents Phase 1b/2 IVT and Phase 2 SC Belzupacap Sarotalocan Data

Clinical Evaluation of Belzupacap Sarotalocan (AU-011), a First-in-Class Targeted Therapy for Choroidal Melanoma with Intravitreal or Suprachoroidal Route of Administration